Pliant Therapeutics (NASDAQ:PLRX) Bolsa

PLIANT THERAPEUTICS INC

Pliant Therapeutics

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Pliant Therapeutics Inc

AmpliTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 81.25 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $3.60 million which beat the analyst consensus estimate of $3.00 million by 19.97 percent. This is a 56.96 percent increase over sales of $2.29 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

AMPG

AmpliTech Gr Q1 EPS $(0.09) Misses $(0.08) Estimate, Sales $3.60M Beat $3.00M Estimate

Needham analyst Laura Martin reiterates DoubleVerify Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with a Buy and maintains $18 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on DoubleVerify Holdings, Maintains $18 Price Target

Canaccord Genuity analyst George Gianarikas maintains Aeva Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) with a Buy and raises the price target from $9.5 to $16.

AEVA

Canaccord Genuity Maintains Buy on Aeva Technologies, Raises Price Target to $16

Incannex Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) reported quarterly losses of $(0.20) per share. This is a 47.37 percent increase over losses of $(0.38) per share from the same period last year.

IXHL

Incannex Healthcare Q3 EPS $(0.20) Up From $(0.38) YoY

-- Early clinical data indicates that Pre-existing and treatment-induced anti-Ad5 neutralizing antibodies do not impact the safety and effectiveness of PCRX-201 –
-- An oral presentation of the data to be featured at the ASGCT Annual Meeting --
BRISBANE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCRX#NASDAQ">PCRX</a>), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced new preliminary data which suggests that clinical immunogenicity does not reduce sustained improvements in knee pain, stiffness and function provided by its gene therapy candidate, PCRX-201 (enekinragene inzadenovec), following local administration in patients with mild, moderate, as well as severe osteoarthritis of the knee. The research findings are being presented during a podium session at the American Society of Gene &amp; Cell Therapy (ASGCT) Annual Meeting in New Orleans on May 15, 2025, at 2:15 CT.

PCRX

Pacira Biosciences: New Preliminary Data Suggests Clinical Immunogenicity Does Not Reduce Sustained Improvements In Knee Pain, Stiffness And Function Provided By Gene Therapy Candidate, PCRX-201

TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) confirming FY 2025 guidance of at least 50% revenue growth.

Guidance

TLSI

TriSalus Life Sciences confirming FY 2025 guidance of at least 50% revenue growth.

Hillenbrand, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) announced today that Robert "Bob" VanHimbergen, Senior Vice President and Chief Financial Officer, has decided to take another position outside of the company, effective June 27, 2025.
Upon Mr. VanHimbergen's departure, Megan Walke, Vice President, Corporate Controller and Chief Accounting Officer (CAO), will serve as Interim CFO. Ms. Walke has been with Hillenbrand for 14 years, holding key financial leadership roles, including as CAO since May 2022, and formerly worked in public accounting for nine years. The company has engaged a leading executive search firm to conduct a comprehensive search for a permanent CFO.

Management

Hillenbrand Announces Robert "Bob" Vanhimbergen, Senior Vice President And CFO, Has Decided To Take Another Position Outside Of The Company, Effective June 27, 2025; Megan Walke, Vice President, Corporate Controller And Chief Accounting Officer, Will Serve As Interim CFO

AMRX

Amneal Pharmaceuticals Receives FDA Approval For Brekiya Injection In Acute Treatment Of Migraine And Cluster Headaches In Adults

Galectin Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GALT#NASDAQ">GALT</a>) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.20) by 25 percent. This is a 21.05 percent increase over losses of $(0.19) per share from the same period last year.

GALT

Galectin Therapeutics Q1 EPS $(0.15) Beats $(0.20) Estimate

Bitcoin Depot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTM#NASDAQ">BTM</a>) .

Bitcoin Depot expects revenue in the Q2 2025 to grow low-to-mid-single digits on a percentage basis from the Q2 2024

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

Chemomab Therapeutics Q1 EPS $(0.007) Up From $(0.014) YoY

WIIM

MESO

Mesoblast shares are trading higher after the company secured a 7-year FDA orphan-drug exclusivity for Ryoncil in steroid-refractory pediatric graft versus host disease.

TLSA

Tiziana Life Sciences: Publishes New Study In Journal Of 'Clinical Nuclear Medicine' Demonstrating That Intranasal Administration Of Foralumab Reduces Neuroinflammation In Alzheimer's

Needham analyst Laura Martin reiterates Magnite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Buy and maintains $18 price target.

MGNI

Needham Reiterates Buy on Magnite, Maintains $18 Price Target

<h3>Gainers</h3>
<ul>
<li>Token Cat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TC#NASDAQ">TC</a>) shares rose 13.3% to $0.85 during Thursday's pre-market session. The company's market cap stands at $2.6 million. </li>
<li>TruGolf Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) shares rose 10.16% to $0.26. The company's market cap stands at $11.4 million. </li>
<li>Ibotta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>) shares increased by 7.28% to $53.78. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONE#NASDAQ">UONE</a>) shares moved upwards by 7.22% to $1.78. The company's market cap stands at $85.2 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Intelligent Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTJ#NASDAQ">INTJ</a>) shares rose 6.71% to $0.64. The market value of their outstanding shares is at $8.4 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) shares moved upwards by 6.63% to $0.62. The company's market cap stands at $6.1 million. As per the press release, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) stock fell 16.8% to $0.63 during Thursday's pre-market session. The company's market cap stands at $16.5 million. </li>
<li>Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) shares fell 14.78% to $1.9. The company's market cap stands at $246.7 million. </li>
<li>HWH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) stock fell 12.36% to $1.56. The company's market cap stands at $10.1 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) stock fell 11.89% to $0.81. The company's market cap stands at $7.7 million. </li>
<li>NextPlat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPL#NASDAQ">NXPL</a>) shares declined by 9.38% to $0.58. The market value of their outstanding shares is at $15.0 million. As per the press release, Q1 earnings came out today. </li>
<li>Antelope Ent Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares decreased by 7.5% to $2.47. The market value of their outstanding shares is at $8.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AEHL

IBTA

INTJ

MITQ

NXPL

SEAT

TNMG

TRUG

UONE

VSME

12 Communication Services Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares increased by 85.4% to $0.84 during Thursday's pre-market session. The company's market cap stands at $20.8 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares moved upwards by 43.64% to $0.05. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) shares rose 40.74% to $1.9. The market value of their outstanding shares is at $11.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock rose 35.69% to $0.22. The company's market cap stands at $11.6 million. </li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) stock rose 22.33% to $8.6. The company's market cap stands at $377.4 million. </li>
<li>Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) stock increased by 20.25% to $2.85. The company's market cap stands at $250.1 million. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock fell 82.1% to $0.04 during Thursday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock declined by 37.35% to $0.18. The market value of their outstanding shares is at $5.1 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock fell 24.51% to $0.17. The market value of their outstanding shares is at $24.1 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>IN8bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) shares declined by 20.66% to $0.12. The company's market cap stands at $10.5 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) stock declined by 20.16% to $3.05. The company's market cap stands at $2.5 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares decreased by 16.96% to $0.69. The company's market cap stands at $83.2 million. As per the press release, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AYTU

BDSX

EKSO

HCTI

INAB

IVVD

KLTO

NAOV

NCNA

NNNN

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares rose 226.7% to $0.91 during Thursday's pre-market session. The market value of their outstanding shares is at $28.9 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock increased by 115.56% to $0.21. The company's market cap stands at $30.6 million. </li>
<li>Innovative Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISSC#NASDAQ">ISSC</a>) stock rose 27.39% to $9.36. The market value of their outstanding shares is at $164.2 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>NV5 Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>) shares rose 16.65% to $21.99. The company's market cap stands at $1.4 billion. </li>
<li>Acuren (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TIC#AMEX">TIC</a>) stock moved upwards by 13.43% to $11.99. The company's market cap stands at $1.4 billion. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares moved upwards by 9.33% to $0.43. The market value of their outstanding shares is at $5.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) shares fell 29.3% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $18.5 million. </li>
<li>High-Trend International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock decreased by 19.13% to $0.32. The market value of their outstanding shares is at $39.1 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) stock decreased by 16.69% to $5.09. The market value of their outstanding shares is at $850.9 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares decreased by 14.02% to $0.22. The company's market cap stands at $4.6 million. </li>
<li>T1 Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TE#NYSE">TE</a>) shares declined by 13.55% to $1.34. The company's market cap stands at $188.0 million. As per the news, the Q1 earnings report came out today. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock fell 10.89% to $0.25. The company's market cap stands at $7.4 million. As per the press release, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

HTCO

ISSC

NVEE

PGHL

SHLS

UGRO

WATT

WLGS

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) stock moved upwards by 15.1% to $0.91 during Thursday's pre-market session. The company's market cap stands at $171.2 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock increased by 11.37% to $1.57. The company's market cap stands at $9.6 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 10.31% to $1.14. The market value of their outstanding shares is at $8.0 million. </li>
<li>MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) shares moved upwards by 6.84% to $3.9. The company's market cap stands at $140.6 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) shares rose 6.48% to $4.6. The company's market cap stands at $95.6 million. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) shares moved upwards by 6.08% to $0.42. The market value of their outstanding shares is at $39.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares fell 20.6% to $2.08 during Thursday's pre-market session. The company's market cap stands at $125.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock declined by 18.04% to $1.5. </li>
<li>DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) stock fell 13.95% to $14.25. The company's market cap stands at $2.5 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock fell 12.64% to $5.81. The company's market cap stands at $525.8 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock decreased by 9.81% to $0.92. The company's market cap stands at $96.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) stock fell 9.32% to $0.55. The company's market cap stands at $10.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MOVE

NVNI

RCAT

REKR

SGMA

SMRT

SVRE

UBXG

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Synergy CHC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNYR#NASDAQ">SNYR</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. The company reported quarterly sales of $8.17 million.

SNYR

Synergy CHC Q1 EPS $0.10 Beats $0.07 Estimate, Sales $8.17M Lower Than $9.41M YoY

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) with a Buy and lowers the price target from $13 to $12.

Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12

Health Care

Press Releases

General

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Legal

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics – PLRX

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. – PLRX

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Comments

Pliant Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL